ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 83 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,420,477 | -21.9% | 169,306 | -7.5% | 0.01% | -30.0% |
| Q1 2023 | $1,817,885 | +41.3% | 183,070 | -1.0% | 0.01% | +42.9% |
| Q4 2022 | $1,286,862 | +6.5% | 184,894 | -18.3% | 0.01% | -12.5% |
| Q3 2022 | $1,208,000 | +345.8% | 226,197 | +233.1% | 0.01% | +300.0% |
| Q2 2022 | $271,000 | +298.5% | 67,914 | +315.5% | 0.00% | – |
| Q2 2020 | $68,000 | -72.4% | 16,346 | -83.6% | 0.00% | -100.0% |
| Q1 2020 | $246,000 | -52.7% | 99,722 | +11.4% | 0.00% | -50.0% |
| Q4 2019 | $520,000 | +27.8% | 89,497 | +16.0% | 0.00% | +33.3% |
| Q3 2019 | $407,000 | -29.2% | 77,172 | -19.5% | 0.00% | -25.0% |
| Q2 2019 | $575,000 | -22.4% | 95,859 | +16.8% | 0.00% | -20.0% |
| Q1 2019 | $741,000 | +89.0% | 82,084 | +74.0% | 0.01% | +66.7% |
| Q4 2018 | $392,000 | – | 47,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
| Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
| Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
| Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
| Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
| APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
| JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
| Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |